Points of therapeutic intervention along the Wnt signaling pathway in hepatocellular carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Signaling Pathways

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
• The WNT/Frizzled-mediated signaling pathway is implicated in hepatic carcinogenesis.
• Aberrant activation of WNT/β-catenin signaling drives HCC progression through target genes controlling cell proliferation and survival.

Purpose of the Study:

• To review potential molecular targets within the canonical WNT signaling pathway for HCC treatment.
• To discuss the therapeutic potential of targeting WNT pathway components in HCC.

Main Methods:

• Literature review of studies on WNT signaling in HCC.
• Analysis of deregulated WNT/β-catenin signaling components in hepatic carcinogenesis.
• Identification of potential molecular targets and their therapeutic relevance.

Main Results:

• Disruption of WNT/β-catenin signaling demonstrates anti-cancer effects in HCC.
• Several molecular targets within the WNT pathway are identified as potentially useful for HCC therapy.
• Currently, no WNT pathway-targeting therapeutics are in clinical evaluation for HCC.

Conclusions:

• The WNT/β-catenin signaling pathway is a critical target for HCC treatment development.
• Further research into WNT pathway inhibitors could lead to novel therapeutic strategies for HCC.
• Targeted therapies modulating WNT signaling hold promise for improving outcomes in hepatocellular carcinoma.